Efficacy of tamsulosin or tadalafil for voiding disorders in I-125 prostate seed implant patients

Efficacy of tamsulosin or tadalafil for voiding disorders in I-125 prostate seed implant patients - Medications for I-125 prostate seed implant patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017825

Enrollment

120

Registered

2015-06-06

Start date

2015-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

tamsulosin tadalafil

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: prostate cancer eligible for I125 seed implant

Exclusion criteria

Exclusion criteria: prostate cancer not eligible for I125 seed implant

Design outcomes

Primary

Measure	Time frame
voiding parameters	—

Countries

Japan

Contacts

Public ContactRyuichi Mizuno MD

Keio university, school of medicine Department of Urology

mizunor@keio.jp03-5363-3825

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026